(ATDN) SC-49483

(ATDN) SC-49483

Treatment Review No. 11; April 1994

Syncytia formation is the term for when cells of the immune system - both those that are infected with HIV as well as those that are not - get stuck together. The immune system then targets these clumps of cells and removes them from the blood. This leaves less cells to fight against HIV and other types of infections. A trial for a new drug that may help prevent syncytia formation is enrolling in New York City. The drug, SC-49483, will be compared to AZT. To participate, you must have between 50 and 350 T4 cells. If you are already taking AZT, you must have been taking it for less than 6 months.

940401
ATR01105

Always watch for outdated information. This article first appeard in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1994 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1994. AEGIS.